Open AccessThe antimicrobial peptide alpha defensin correlates to type 2 diabetes via the advanced glycation end products pathway
Author(s) -
Mohammed ElMowafy,
Abdelaziz Elgaml,
Naglaa Abass,
Amany A. Mousa,
Mohamed N. Amin
Publication year - 2022
Publication title -
african health sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 44
eISSN - 1729-0503
pISSN - 1680-6905
DOI - 10.4314/ahs.v22i1.37
Subject(s) - medicine , defensin , type 2 diabetes , glycation , diabetes mellitus , body mass index , immunology , beta defensin , inflammation , endocrinology , gastroenterology , antimicrobial , innate immune system , immune system , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom